0001179110-11-012208.txt : 20110815 0001179110-11-012208.hdr.sgml : 20110815 20110815164526 ACCESSION NUMBER: 0001179110-11-012208 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20110815 FILED AS OF DATE: 20110815 DATE AS OF CHANGE: 20110815 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: WATSON PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000884629 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 953872914 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: MORRIS CORPORATE CENTER III STREET 2: 400 INTERPACE PARKWAY CITY: PARSIPPANY STATE: NJ ZIP: 07054 BUSINESS PHONE: 9092701400 MAIL ADDRESS: STREET 1: MORRIS CORPORATE CENTER III STREET 2: 400 INTERPACE PARKWAY CITY: PARSIPPANY STATE: NJ ZIP: 07054 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: TURNER ANDREW L CENTRAL INDEX KEY: 0000925546 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-13305 FILM NUMBER: 111037138 MAIL ADDRESS: STREET 1: 2801 WESTERN AVE. STREET 2: PENTHOUSE #2 CITY: SEATTLE STATE: WA ZIP: 98121 4 1 edgar.xml FORM 4 - X0304 4 2011-08-15 0 0000884629 WATSON PHARMACEUTICALS INC WPI 0000925546 TURNER ANDREW L 4121 W. DRAVUS STREET SEATTLE WA 98199 1 0 0 1 Non-Executive Chairman Common Stock, par value $0.0033 2011-08-15 4 S 0 1000 64.745 D 7177 D The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $64.74 to $64.75, inclusive. The reporting person undertakes to provide to Watson Pharmaceuticals, Inc., any security holder of Watson Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. Includes shares of restricted stock issued pursuant to the Fourth Amendment and Restatement of the 2001 Incentive Award Plan of Watson Pharmaceuticals, Inc. /s/ANDREW L. TURNER 2011-08-15